Mutations and/or deletions of p300 and/or CBP genes have been also reported in several types of cancer, as lung, colon, breast and ovarian carcinomas [8–10], indicating a p300 role as tumor suppressor, and suggesting that it may play a role in the development of a subset of human cancers. This evidence concerns the gene EP300 and neoplasm.